Calliditas Therapeutics: First Day of Trading in the US

Research Note

2020-06-05

14:05

Calliditas will have its first day of trading on The Nasdaq Global Select Market today June 5th. Gross proceeds from the US IPO and the European private placement amount to SEK ~830 million before transaction costs. In addition, if the over-allotment option is exercised in full, the global offering will bring in SEK ~950 million before transaction costs. We will return with a more in-depth comment once the transactions have been closed.

LS

Ludvig Svensson

Sign up for free to continue

Already a member?

Sign in

Disclosures and disclaimers

Premium Plan required to unlock

Unlock companies to access

more high quality research.